Glaxo Australia Ply., Ltd.
Country not established
- Devices
- 1
What Glaxo Australia Ply., Ltd. makes
Glaxo Australia Pty. Ltd. manufactures peak flow meters, such as the Airflowmeter, used to measure lung function and assess asthma or chronic obstructive pulmonary disease (COPD) control.
These devices are classified as Class II under FDA regulations and are listed via the 510(k) clearance process. The company is based in the United States.
Catalogue
Airflometer Ref K780894
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Glaxo Australia Ply., Ltd. have in the registry?
The registry currently lists 1 device for Glaxo Australia Ply., Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Glaxo Australia Ply., Ltd.'s devices?
Among its 1 most recently registered device, Glaxo Australia Ply., Ltd. has devices listed in FDA 510(k) (1 device).
What risk classes do Glaxo Australia Ply., Ltd.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Glaxo Australia Ply., Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Glaxo Australia Ply., Ltd. in the registry?
The most recently registered devices listed for Glaxo Australia Ply., Ltd. include AIRFLOMETER.